Both top-ranked cancer signaling pathways, glioblastoma multiforme signaling and Her-2 breast cancer signaling, also contain some but not all differentially expressed Wnt-β-catenin signaling genes present in the HBL tumor transcriptome. This evidence concerns the gene ERBB2 and hepatoblastoma.